文献速递冠心病血脂与心血管预防

氧化磷脂PGPC通过NPC1诱导STX17乙酰化和泛素化抑制内皮自噬体-溶酶体融合而损害血管新生

The Oxidized Phospholipid PGPC Impairs Angiogenesis by Inhibiting Endothelial Autophagosomal-Lysosomal Fusion Through NPC1-Induced Syntaxin 17 Acetylation and Ubiquitination.
PubMed 文献 · Circulation · 2026-10-06

该研究探讨氧化磷脂PGPC对缺血心脏血管新生的影响及机制。在CAD患者中血浆PGPC升高且与CAD严重程度正相关、与冠脉侧支形成负相关;体外和C57BL/6J小鼠模型显示PGPC抑制内皮细胞迁移、管腔形成及缺血组织血管新生。机制上PGPC通过CD36上调NPC1,促进STX17乙酰化及泛素化降解并竞争性结合VAMP8,抑制自噬体-溶酶体融合及eNOS/ERK1/2/NO通路;靶向PGPC、NPC1或STX17可逆转其抑制作用。

要点

  • CAD患者血浆PGPC升高,与CAD严重程度正相关、与冠脉侧支形成负相关。
  • PGPC抑制内皮细胞迁移、管腔形成及小鼠缺血组织血管新生,并削弱VEGFA促血管新生效应。
  • PGPC经CD36-NPC1轴促进STX17乙酰化和泛素化降解,阻断自噬体-溶酶体融合。

核心结论

  • PGPC通过上调NPC1促进STX17乙酰化和泛素介导降解,减少STX17与VAMP8结合,抑制自噬体-溶酶体融合和血管新生。
  • 靶向PGPC、NPC1或STX17可能成为促进CAD患者血管新生的新治疗策略。

研究设计与样本

  • 研究检测了CAD患者血浆PGPC浓度,并在培养内皮细胞及C57BL/6J小鼠中评估PGPC对血管新生的影响。
  • 体内实验采用皮下Matrigel plug assay、后肢缺血模型和心肌梗死模型。
  • 研究评估了自噬流及自噬和血管新生相关蛋白的表达与修饰。

主要发现

  • CAD患者血浆PGPC水平升高,与CAD严重程度正相关,与冠状动脉侧支动脉形成负相关。
  • PGPC抑制内皮细胞迁移和管腔形成,抑制Matrigel plug内血管新生,并减少后肢缺血模型的血流恢复。
  • 在小鼠心肌梗死模型中,PGPC减弱缺血心肌的血管新生,并显著抑制VEGFA在缺血心脏诱导的促血管新生效应。
  • PGPC通过CD36上调NPC1,NPC1通过招募ACAT1促进STX17乙酰化及后续泛素化降解,并与STX17竞争结合VAMP8,抑制eNOS、ERK1/2表达及一氧化氮生成。
  • 氧化磷脂中和抗体E06、STX17过表达或NPC1沉默通过恢复自噬流逆转PGPC对血管新生的抑制作用。

临床怎么用

  • 血浆PGPC水平可能作为反映CAD严重程度和冠状动脉侧支形成能力的生物标志物。
  • 针对PGPC-NPC1-STX17轴进行干预可能促进缺血心脏的血管新生。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Angiogenesis is essential for the recovery of ischemic hearts with coronary artery disease (CAD). PGPC (1-palmitoyl-2-glutamyl-sn-glycero-3-phosphocholine) is a major phospholipid oxidation product in atherosclerotic lesions. Autophagy participates in angiogenesis. However, whether PGPC affects angiogenesis in ischemic hearts by regulating autophagy remains unclear. METHODS: Plasma PGPC concentrations were quantified and the effects of PGPC on angiogenesis were evaluated in cultured endothelial cells and in vivo using a subcutaneous Matrigel plug assay, as well as in hindlimb ischemia and myocardial infarction models in C57BL/6J mice. Autophagic flux and the expression and modification of proteins associated with autophagy and angiogenesis were also assessed. RESULTS: Plasma PGPC levels were increased in patients with CAD, and they were positively correlated with the severity of CAD and negatively correlated with coronary collateral artery formation. PGPC inhibited endothelial cell migration and tube formation. PGPC suppressed neovascularization in Matrigel plugs and reduced blood flow recovery in hindlimb ischemia. In a mouse model of myocardial infarction, PGPC attenuated angiogenesis in the ischemic myocardium. These proangiogenic effects induced by VEGFA (vascular endothelial growth factor A) in ischemic hearts were significantly inhibited by PGPC. Mechanistically, PGPC inhibited the expression of STX17 (syntaxin 17), a crucial molecule that controls autophagosomal-lysosomal fusion by promoting the acetylation and subsequent ubiquitination and degradation of STX17. PGPC upregulated the expression of NPC1 (NPC intracellular cholesterol transporter 1) through CD36 (cluster of differentiation 36). NPC1 not only promoted the acetylation and subsequent ubiquitination and degradation of STX17 through the recruitment of ACAT1 (acetyl-CoA acetyltransferase 1), but also competed with STX17 to bind VAMP8 (vesicle-associated membrane protein 8), leading to inhibition of the expression of eNOS (endothelial nitric oxide synthase), ERK1/2 (extracellular signal-regulated kinase 1/2), and nitric oxide production. Oxidized phospholipid-neutralizing antibody E06, STX17 overexpression, or silencing of NPC1 reversed the inhibitory effect of PGPC on angiogenesis by restoring autophagic flux. CONCLUSIONS: PGPC promotes the acetylation and subsequent ubiquitin-mediated degradation of STX17 by increasing NPC1, leading to a reduction in the level of STX17 associated with VAMP8, which inhibits autophagosomal-lysosomal fusion and angiogenesis. Targeting PGPC, NPC1, or STX17 may represent novel therapeutic approaches to promote angiogenesis in patients with CAD.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Li L, Gao JJ, Kang YT, et al. The Oxidized Phospholipid PGPC Impairs Angiogenesis by Inhibiting Endothelial Autophagosomal-Lysosomal Fusion Through NPC1-Induced Syntaxin 17 Acetylation and Ubiquitination. Circulation. 2026. PMID: 42836285. doi:10.1161/CIRCULATIONAHA.126.079506

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。